Covered recipient · General Payments record
MANAN SHAH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurocritical Care
General Payments · PY2018–2024
$2,750.10
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.78 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $81.33 | 3 |
| UCB, Inc. | $53.09 | 2 |
| JAZZ PHARMACEUTICALS INC. | $37.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.84 | 2 |
| Amgen Inc. | $27.67 | 1 |
| Harrow Eye, LLC | $23.16 | 1 |
| Olympus America Inc. | $19.94 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $18.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093957866 | CMS |
| Amgen Inc. | $27.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680882 | CMS |
| Harrow Eye, LLC | $23.16 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145615240 | CMS |
| JAZZ PHARMACEUTICALS INC. | $37.91 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150212253 | CMS |
| Olympus America Inc. | $19.94 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108468094 | CMS |
| SK Life Science, Inc. | $28.76 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154126338 | CMS |
| SK Life Science, Inc. | $28.11 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154126424 | CMS |
| SK Life Science, Inc. | $24.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154126524 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.26 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137672615 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.58 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137672617 | CMS |
| UCB, Inc. | $22.60 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445989 | CMS |
| UCB, Inc. | $30.49 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.